Post-stenotic aortic dilatation

Aortic stenosis is the most common valvular heart disease affecting up to 4% of the elderly population. It can be associated with dilatation of the ascending aorta and subsequent dissection. Post-stenotic dilatation is seen in patients with AS and/or aortic regurgitation, patients with a haemodynamically normal bicuspid aortic valve and following aortic valve replacement. Controversy exists as to whether to replace the aortic root and ascending aorta at the time of aortic valve replacement, an operation that potentially carries a higher morbidity and mortality.The aetiology of post-stenotic aortic dilatation remains controversial. It may be due to haemodynamic factors caused by a stenotic valve, involving high velocity and turbulent flow downstream of the stenosis, or due to intrinsic pathology of the aortic wall. This may involve an abnormality in the process of extracellular matrix remodelling in the aortic wall including inadequate synthesis, degradation and transport of extracellular matrix proteins.This article reviews the aetiology, pathology and management of patients with post-stenotic aortic dilatation.

[1]  L. J. Dacey,et al.  Stability of Ascending Aortic Dilatation Following Aortic Valve Replacement , 2003, Circulation.

[2]  B. Mokri,et al.  Familial aorto-cervicocephalic arterial dissections and congenitally bicuspid aortic valve. , 1995, Stroke.

[3]  J. Roos‐Hesselink,et al.  Is a bicuspid aortic valve a risk factor for adverse outcome after an autograft procedure? , 2004, The Annals of thoracic surgery.

[4]  K. Bielenberg,et al.  Structural and biomolecular changes in aorta and pulmonary trunk of patients with aortic aneurysm and valve disease: implications for the Ross procedure. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[5]  J. Shirani,et al.  Matrix metalloproteinase expression in nonrheumatic aortic stenosis. , 2000, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[6]  M. Thubrikar,et al.  The congenitally bicuspid aortic valve: how does it function? Why does it fail? , 2004, The Annals of thoracic surgery.

[7]  H. Reichenspurner,et al.  Ross and Ross-Konno procedure in children and adolescents: mid-term results. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[8]  W. Pearce,et al.  Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. , 1997, Surgery.

[9]  Robert P. Thompson,et al.  Effects of Deletion of the Tissue Inhibitor of Matrix Metalloproteinases-1 Gene on the Progression of Murine Thoracic Aortic Aneurysms , 2004, Circulation.

[10]  J. Pepper,et al.  The Tailor of Gloucester: a jacket for the Marfan's aorta , 2004, The Lancet.

[11]  C. Hamm,et al.  Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. , 2005, European heart journal.

[12]  Robert W. Thompson,et al.  Treatment With Simvastatin Suppresses the Development of Experimental Abdominal Aortic Aneurysms in Normal and Hypercholesterolemic Mice , 2005, Annals of surgery.

[13]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[14]  Thoralf M Sundt,et al.  The influence of mechanical properties on wall stress and distensibility of the dilated ascending aorta. , 2003, The Journal of thoracic and cardiovascular surgery.

[15]  J. Stanley,et al.  Nitric oxide inhibition increases aortic wall matrix metalloproteinase-9 expression. , 2002, The Journal of surgical research.

[16]  M. Thubrikar,et al.  Conservative operation in the management of annular dilatation and ascending aortic aneurysm. , 1994, The Annals of thoracic surgery.

[17]  R. Devereux,et al.  Association of aortic dilation with regurgitant, stenotic and functionally normal bicuspid aortic valves. , 1992, Journal of the American College of Cardiology.

[18]  S. Armstrong,et al.  Dilation of the pulmonary autograft after the Ross procedure. , 2000, The Journal of thoracic and cardiovascular surgery.

[19]  C. Otto,et al.  Association of Angiotensin-Converting Enzyme With Low-Density Lipoprotein in Aortic Valvular Lesions and in Human Plasma , 2002, Circulation.

[20]  R. Zanoli,et al.  Aortic dimensions in patients with bicuspid aortic valve without significant valve dysfunction. , 2005, The American journal of cardiology.

[21]  Vivekanand Allada,et al.  Frequency of aortic root dilation in children with a bicuspid aortic valve. , 2004, The American journal of cardiology.

[22]  J. Heikkilä,et al.  Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. , 1993, Journal of the American College of Cardiology.

[23]  Erwan Donal,et al.  Influence of structural geometry on the severity of bicuspid aortic stenosis. , 2004, American journal of physiology. Heart and circulatory physiology.

[24]  A. Hunter,et al.  A prospective study to assess the frequency of familial clustering of congenital bicuspid aortic valve. , 1997, Journal of the American College of Cardiology.

[25]  A. Gallego,et al.  Coronary artery anomalies and aortic valve morphology in the Syrian hamster , 2000, Laboratory animals.

[26]  W. Roberts,et al.  The congenitally bicuspid aortic valve. A study of 85 autopsy cases. , 1970, The American journal of cardiology.

[27]  M. Zacher,et al.  Aortic root replacement versus aortic valve replacement: a case-match study. , 2001, The Annals of thoracic surgery.

[28]  S. Nakatani,et al.  Failure to Prevent Progressive Dilation of Ascending Aorta by Aortic Valve Replacement in Patients With Bicuspid Aortic Valve: Comparison With Tricuspid Aortic Valve , 2003, Circulation.

[29]  C. Hamm,et al.  Relation of N-terminal pro-B-type natriuretic peptide to severity of valvular aortic stenosis. , 2004, The American journal of cardiology.

[30]  C. Ward Clinical significance of the bicuspid aortic valve , 2000, Heart.

[31]  S. Hagl,et al.  Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis. , 2005, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[32]  J. Elefteriades Natural history of thoracic aortic aneurysms: indications for surgery, and surgical versus nonsurgical risks. , 2002, The Annals of thoracic surgery.

[33]  M. Crawford,et al.  Prevalence of aortic root dilatation and small aortic roots in valvular aortic stenosis. , 2001, The American journal of cardiology.

[34]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[35]  R. Prescott,et al.  A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. , 2005, The New England journal of medicine.

[36]  W. Roberts,et al.  Frequency by Decades of Unicuspid, Bicuspid, and Tricuspid Aortic Valves in Adults Having Isolated Aortic Valve Replacement for Aortic Stenosis, With or Without Associated Aortic Regurgitation , 2005, Circulation.

[37]  M. Borger,et al.  Should the ascending aorta be replaced more frequently in patients with bicuspid aortic valve disease? , 2004, The Journal of thoracic and cardiovascular surgery.

[38]  G. Thiene,et al.  Aortic root dilatation in young men with normally functioning bicuspid aortic valves , 1999, Heart.

[39]  R. E. Luna,et al.  Immunohistochemistry of matrix metalloproteinases and their inhibitors in thoracic aortic aneurysms and aortic valves of patients with Marfan's syndrome. , 1998, Circulation.

[40]  W. P. Harvey,et al.  Development and progression of aortic valve stenosis: Atherosclerosis risk factors—a causal relationship? a clinical morphologic study , 1991, Clinical cardiology.

[41]  L. Trombley,et al.  Matrix metalloproteinase activity in thoracic aortic aneurysms associated with bicuspid and tricuspid aortic valves. , 2004, The Journal of thoracic and cardiovascular surgery.

[42]  D. Brotman,et al.  Can glucocorticoid homeostasis explain the antiatherogenic effect of peripheral adiposity? , 2003, Circulation.

[43]  J. Coselli,et al.  Matrix metalloproteinases in ascending aortic aneurysms: bicuspid versus trileaflet aortic valves. , 2005, The Journal of surgical research.

[44]  Stefan Agewall,et al.  Matrix metalloproteinases and cardiovascular disease. , 2006, European heart journal.

[45]  A. Becker,et al.  Anomalies Associated with Coarctation of Aorta Particular Reference to Infancy , 1970, Circulation.

[46]  M. Schemper,et al.  Statins but Not Angiotensin-Converting Enzyme Inhibitors Delay Progression of Aortic Stenosis , 2004, Circulation.

[47]  J. Elefteriades,et al.  Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta. , 2004, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[48]  U. Demirkılıç,et al.  Surgical Approach to Ascending Aorta in Bicuspid Aortic Valve , 2003, Journal of cardiac surgery.

[49]  J. Bavaria,et al.  Bicuspid aortic valves are associated with aortic dilatation out of proportion to coexistent valvular lesions. , 2000, Circulation.

[50]  A. Della Corte,et al.  Different patterns of extracellular matrix protein expression in the convexity and the concavity of the dilated aorta with bicuspid aortic valve: preliminary results. , 2005, The Journal of thoracic and cardiovascular surgery.

[51]  Y. Soini,et al.  Expression of MMP2, MMP9, MT1‐MMP, TIMP1, and TIMP2 mRNA in valvular lesions of the heart , 2001, The Journal of pathology.

[52]  M. Campbell Calcific aortic stenosis and congenital bicuspid aortic valves. , 1968, British heart journal.

[53]  L. Barozzi,et al.  Fate of the Aortic Root Late After Ross Operation , 2003, Circulation.

[54]  A. G. Gittenberger-de Groot,et al.  The neural crest as a possible pathogenetic factor in coarctation of the aorta and bicuspid aortic valve. , 1991, The Journal of thoracic and cardiovascular surgery.

[55]  M. Roman,et al.  Phenotypic features and impact of beta blocker or calcium antagonist therapy on aortic lumen size in the Marfan syndrome. , 1999, The American journal of cardiology.

[56]  D. Stewart,et al.  Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. , 2000, Circulation.

[57]  E. Murphy,et al.  Progression of aortic dilatation and the benefit of long-term beta-adrenergic blockade in Marfan's syndrome. , 1994, The New England journal of medicine.

[58]  Bonnie K. Lind,et al.  Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. , 1997, Journal of the American College of Cardiology.

[59]  B. Strauss,et al.  Vascular matrix remodeling in patients with bicuspid aortic valve malformations: implications for aortic dilatation. , 2003, The Journal of thoracic and cardiovascular surgery.

[60]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[61]  M. Slater,et al.  Modification to the Ross procedure to prevent autograft dilatation. , 2005, Seminars in thoracic and cardiovascular surgery. Pediatric cardiac surgery annual.

[62]  A. Usui,et al.  Natural history of a dilated ascending aorta after aortic valve replacement. , 2005, Circulation journal : official journal of the Japanese Circulation Society.

[63]  Catherine M. Otto,et al.  Clinical Factors Associated With Calcific Aortic Valve Disease , 1997 .

[64]  R. Shemin,et al.  Improved clinical outcomes after operation of the proximal aorta: a 10-year experience. , 1999, The Annals of thoracic surgery.

[65]  T. Sundt,et al.  Options for repair of a bicuspid aortic valve and ascending aortic aneurysm. , 2000, The Annals of thoracic surgery.

[66]  G. Thiene,et al.  Fusion of valve cushions as a key factor in the formation of congenital bicuspid aortic valves in Syrian hamsters , 1996, The Anatomical record.

[67]  T. David,et al.  Histologic abnormalities of the ascending aorta and pulmonary trunk in patients with bicuspid aortic valve disease: clinical relevance to the ross procedure. , 1999, The Journal of thoracic and cardiovascular surgery.

[68]  S. Verma,et al.  Clinical and Pathophysiological Implications of a Bicuspid Aortic Valve , 2002, Circulation.

[69]  C. Roobottom,et al.  Dilatation of the aorta in pure, severe, bicuspid aortic valve stenosis. , 2004, American heart journal.

[70]  A. B. Stewart,et al.  Coarctation of the aorta life and health 20-44 years after surgical repair. , 1993, British heart journal.

[71]  T. Rea,et al.  A Community-Based Study , 2004 .